Non-cardiovascular comorbidities in heart failure patients and their impact on prognosis
Kardiol Pol. 2021;79(5):493-502. doi: 10.33963/KP.15934.ABSTRACTWith the aging of the population and improvement of life expectancy of patients with heart disease, there is an increase in non-cardiovascular (CV) comorbidities affecting chronic heart failure (HF) patients. The increased prevalence of different CV and non-CV comorbidities is a rising problem in the management of patients with HF, mostly because these comorbidities may lead to poor prognosis, increase of hospitalizations and mortality rate. Recently, important data from multicenter randomized studies point to diabetes mellitus or iron deficiency as new pharmacological targets, and this highlights the need of broad expertise for the 21st-century cardiologist. The management of HF should take into account non-CV comorbidities. In this review, we discuss novel aspects of non-CV comorbidities in HF patients and emphasize the impact on prognosis.PMID:34125921 | DOI:10.33963/KP.15934
Source: Polish Heart Journal - Category: Cardiology Authors: Michele Correale Stefania Paolillo Valentina Mercurio Gaetano Ruocco Carlo G Tocchetti Alberto Palazzuoli Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Disease | Heart Failure | Iron | Poland Health | Study